TEAS Response to Suspension Inquiry

KNOTBODY

Iontas Ltd

Response to Suspension Inquiry or Letter of Suspension

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1822 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Suspension Inquiry or Letter of Suspension


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88482082
LAW OFFICE ASSIGNED LAW OFFICE 111
MARK SECTION
MARK http://uspto.report/TM/88482082/mark.png
LITERAL ELEMENT KNOTBODY
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
PENDING SERIAL NUMBER(S)
Serial number(s) 88267886 and 88267875 should not be used as a citation(s) under Section 2(d), in the event that said serial number(s) mature(s) into a registration(s). The applicant hereby requests removal of this application from suspension, based on the following arguments. If the examining attorney is not persuaded by these arguments, the applicant hereby requests that this application be returned to suspended status, awaiting ultimate disposition of the referenced serial number(s).
ARGUMENT(S)

The undersigned wishes to thank Examining Attorney Ervin for the courtesy of discussing the amendment proposed herein via email exchange on March 17, 2020. 

 

As we discussed, the above amendment to the goods description in class 1 is believed to overcome any likelihood of confusion with the cited BODI marks (BODI (stylized), App. No. 88267886 and BODI, App. No. 88267875) and our client’s KNOTBODY.  

 

In view of the above, Applicant respectfully requests withdrawal of the suspension and approval of the application for publication.  In the event that further prosecution is needed and can be accomplished via a telephone conference, the Examining Attorney is encouraged to contact Applicant’s attorney, Thomas D. Bratschun at 303-268-0066.

OWNER SECTION (current)
NAME Iontas Ltd
STREET 82b High Street
CITY Sawston,Cambridgeshire
ZIP/POSTAL CODE CB223HJ
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United Kingdom
OWNER SECTION (proposed)
NAME Iontas Ltd
STREET 82b High Street
CITY Sawston,Cambridgeshire
ZIP/POSTAL CODE CB223HJ
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United Kingdom
EMAIL mail@mewburn.com
GOODS AND/OR SERVICES SECTION (001)(current)
INTERNATIONAL CLASS 001
DESCRIPTION
Chemicals for use in industry and science; biochemicals, namely, polypeptides and antibodies for scientific, laboratory or research purposes; biochemicals, namely, polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, ion channel blocking antibodies for scientific, laboratory or research purposes; biochemicals, namely, ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; biochemicals, namely, antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs
FILING BASIS Section 1(b)
        FOREIGN APPLICATION NUMBER 018037711
        FOREIGN FILING DATE 03/19/2019
GOODS AND/OR SERVICES SECTION (001)(proposed)
INTERNATIONAL CLASS 001
TRACKED TEXT DESCRIPTION
Chemicals for use in industry and science; Chemicals for use in industry and science, excluding nanomaterial-based chemicals; biochemicals, namely, polypeptides and antibodies for scientific, laboratory or research purposes; biochemicals, namely, polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, ion channel blocking antibodies for scientific, laboratory or research purposes; biochemicals, namely, ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; biochemicals, namely, antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs
FINAL DESCRIPTION
Chemicals for use in industry and science, excluding nanomaterial-based chemicals; biochemicals, namely, polypeptides and antibodies for scientific, laboratory or research purposes; biochemicals, namely, polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, ion channel blocking antibodies for scientific, laboratory or research purposes; biochemicals, namely, ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; biochemicals, namely, antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs
FILING BASIS Section 1(b)
       FOREIGN APPLICATION NUMBER 018037711
       FOREIGN APPLICATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY European Union Trademark - EUTM
       FOREIGN FILING DATE 03/19/2019
FILING BASIS Section 44(e)
       FOREIGN REGISTRATION NUMBER 018037711
       FOREIGN REGISTRATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
European Union Trademark - EUTM
       FOREIGN REGISTRATION
       DATE
08/10/2019
       FOREIGN EXPIRATION DATE 03/19/2029
GOODS AND/OR SERVICES SECTION (005)(no change)
GOODS AND/OR SERVICES SECTION (042)(no change)
GOODS AND/OR SERVICES SECTION (044)(no change)
CORRESPONDENCE INFORMATION (current)
NAME Thomas D. Bratschun
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE efs@adseroip.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER 0206.001-TM
CORRESPONDENCE INFORMATION (proposed)
NAME Thomas D. Bratschun
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE efs@adseroip.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER 0206.001-TM
SIGNATURE SECTION
RESPONSE SIGNATURE /TD Bratschun/
SIGNATORY'S NAME Thomas D. Bratschun
SIGNATORY'S POSITION Attorney of Record, Colorado Bar Member
SIGNATORY'S PHONE NUMBER 303-268-0066
DATE SIGNED 03/19/2020
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Thu Mar 19 14:16:36 ET 2020
TEAS STAMP USPTO/RSI-XXX.XX.XXX.X-20
200319141636893018-884820
82-710ba123aa48d8815fa79c
812e0c26b02572ccbc2e0bfb2
f0ba94c922e5806467-N/A-N/
A-20200319132102887853



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1822 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Response to Suspension Inquiry or Letter of Suspension


To the Commissioner for Trademarks:

Application serial no. 88482082 KNOTBODY(Standard Characters, see http://uspto.report/TM/88482082/mark.png) has been amended as follows:
PENDING SERIAL NUMBER(S)
Serial number(s) 88267886 and 88267875 should not be used as a citation(s) under Section 2(d), in the event that said serial number(s) mature(s) into a registration(s). The applicant hereby requests removal of this application from suspension, based on the following arguments. If the examining attorney is not persuaded by these arguments, the applicant hereby requests that this application be returned to suspended status, awaiting ultimate disposition of the referenced serial number(s).

ARGUMENT(S)

The undersigned wishes to thank Examining Attorney Ervin for the courtesy of discussing the amendment proposed herein via email exchange on March 17, 2020. 

 

As we discussed, the above amendment to the goods description in class 1 is believed to overcome any likelihood of confusion with the cited BODI marks (BODI (stylized), App. No. 88267886 and BODI, App. No. 88267875) and our client’s KNOTBODY.  

 

In view of the above, Applicant respectfully requests withdrawal of the suspension and approval of the application for publication.  In the event that further prosecution is needed and can be accomplished via a telephone conference, the Examining Attorney is encouraged to contact Applicant’s attorney, Thomas D. Bratschun at 303-268-0066.


CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 001 for Chemicals for use in industry and science; biochemicals, namely, polypeptides and antibodies for scientific, laboratory or research purposes; biochemicals, namely, polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, ion channel blocking antibodies for scientific, laboratory or research purposes; biochemicals, namely, ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; biochemicals, namely, antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: The applicant has had a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services as of the filing date of the application. (15 U.S.C. Section 1051(b)).

Applicant has made of record the following information concerning a foreign application: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services, and asserts a claim of priority based on [European Union Trademark - EUTM application number 018037711 filed 03/19/2019].

Filing Basis: Section 44(e), Based on Foreign Registration: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and /or services, and submits a copy of [ European Union Trademark - EUTM registration number 018037711 registered 08/10/2019 with a renewal date of __________ and an expiration date of 03/19/2029 ], and translation thereof, if appropriate. 15 U.S.C. Section 1126(e), as amended.

Proposed:
Tracked Text Description: Chemicals for use in industry and science; Chemicals for use in industry and science, excluding nanomaterial-based chemicals; biochemicals, namely, polypeptides and antibodies for scientific, laboratory or research purposes; biochemicals, namely, polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, ion channel blocking antibodies for scientific, laboratory or research purposes; biochemicals, namely, ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; biochemicals, namely, antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugsClass 001 for Chemicals for use in industry and science, excluding nanomaterial-based chemicals; biochemicals, namely, polypeptides and antibodies for scientific, laboratory or research purposes; biochemicals, namely, polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, ion channel blocking antibodies for scientific, laboratory or research purposes; biochemicals, namely, ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; biochemicals, namely, antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; biochemicals, namely, antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs
Filing Basis: Section 1(b), Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services as of the filing date of the application. (15 U.S.C. Section 1051(b)).

Applicant has made of record the following information concerning a foreign application: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services, and asserts a claim of priority based on [European Union Trademark - EUTM application number 018037711 filed 03/19/2019].

Filing Basis: Section 44(e), Based on Foreign Registration: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and /or services, and will submit a copy of [ European Union Trademark - EUTM registration number 018037711 registered 08/10/2019 with a renewal date of __________ and an expiration date of 03/19/2029 ], and translation thereof, if appropriate, before the application may proceed to registration. 15 U.S.C. Section 1126(e), as amended.


APPLICANT AND/OR ENTITY INFORMATION
Applicant proposes to amend the following:
Current: Iontas Ltd a(n) limited company (ltd.), legally organized under the laws of United Kingdom, having an address of
      82b High Street
      Sawston,Cambridgeshire, CB223HJ
      United Kingdom
Proposed: Iontas Ltd, limited company (ltd.) legally organized under the laws of United Kingdom, having an address of
      82b High Street
      Sawston,Cambridgeshire, CB223HJ
      United Kingdom
      Email Address: mail@mewburn.com
Correspondence Information (current):
      Thomas D. Bratschun
      PRIMARY EMAIL FOR CORRESPONDENCE: efs@adseroip.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

The docket/reference number is 0206.001-TM.
Correspondence Information (proposed):
      Thomas D. Bratschun
      PRIMARY EMAIL FOR CORRESPONDENCE: efs@adseroip.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

The docket/reference number is 0206.001-TM.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

Response Suspension Inquiry Signature
Signature: /TD Bratschun/     Date: 03/19/2020
Signatory's Name: Thomas D. Bratschun
Signatory's Position: Attorney of Record, Colorado Bar Member
Signatory's Phone Number: 303-268-0066

Mailing Address:    Thomas D. Bratschun
   ADSERO IP
   
   8210 SOUTHPARK TERRACE
   LITTLETON, Colorado
Mailing Address:    Thomas D. Bratschun
   ADSERO IP
   8210 SOUTHPARK TERRACE
   LITTLETON, Colorado 80120
        
Serial Number: 88482082
Internet Transmission Date: Thu Mar 19 14:16:36 ET 2020
TEAS Stamp: USPTO/RSI-XXX.XX.XXX.X-20200319141636893
018-88482082-710ba123aa48d8815fa79c812e0
c26b02572ccbc2e0bfb2f0ba94c922e5806467-N
/A-N/A-20200319132102887853



uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed